Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 63

1.

The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.

Moore RA, Head MW, Ironside JW, Ritchie DL, Zanusso G, Pyo Choi Y, Priola SA.

PLoS Pathog. 2016 Feb 3;12(2):e1005416. doi: 10.1371/journal.ppat.1005416. eCollection 2016 Feb.

2.

Treatment of Prion Disease with Heterologous Prion Proteins.

Skinner PJ, Kim HO, Bryant D, Kinzel NJ, Reilly C, Priola SA, Ward AE, Goodman PA, Olson K, Seelig DM.

PLoS One. 2015 Jul 2;10(7):e0131993. doi: 10.1371/journal.pone.0131993. eCollection 2015.

3.

Proteomics applications in prion biology and structure.

Moore RA, Faris R, Priola SA.

Expert Rev Proteomics. 2015 Apr;12(2):171-84. doi: 10.1586/14789450.2015.1019481. Review.

PMID:
25795148
4.

Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.

Choi YP, Head MW, Ironside JW, Priola SA.

Am J Pathol. 2014 Dec;184(12):3299-307. doi: 10.1016/j.ajpath.2014.08.005. Epub 2014 Sep 30.

5.

Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis.

Moore RA, Sturdevant DE, Chesebro B, Priola SA.

J Proteome Res. 2014 Nov 7;13(11):4620-34. doi: 10.1021/pr500329w. Epub 2014 Aug 29.

6.
7.

Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.

Timmes AG, Moore RA, Fischer ER, Priola SA.

PLoS One. 2013 Jul 30;8(7):e71081. doi: 10.1371/journal.pone.0071081. Print 2013.

8.

Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease.

Priola SA, Ward AE, McCall SA, Trifilo M, Choi YP, Solforosi L, Williamson RA, Cruite JT, Oldstone MB.

J Virol. 2013 Sep;87(17):9501-10. doi: 10.1128/JVI.00692-13. Epub 2013 Jun 19.

9.

Rabbits are not resistant to prion infection.

Chianini F, Fernández-Borges N, Vidal E, Gibbard L, Pintado B, de Castro J, Priola SA, Hamilton S, Eaton SL, Finlayson J, Pang Y, Steele P, Reid HW, Dagleish MP, Castilla J.

Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5080-5. doi: 10.1073/pnas.1120076109. Epub 2012 Mar 13.

10.

Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice.

Leblanc P, Hasenkrug K, Ward A, Myers L, Messer RJ, Alais S, Timmes A, Priola SA.

PLoS One. 2012;7(1):e30872. doi: 10.1371/journal.pone.0030872. Epub 2012 Jan 25. Erratum in: PLoS One. 2012;7(6). doi:10.1371/annotation/c6b9e78a-451b-4a34-bcd3-24a820bfa32f. Priola, Sue [corrected to Priola, Suzette A].

11.

Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.

Moore RA, Timmes AG, Wilmarth PA, Safronetz D, Priola SA.

Proteomics. 2011 Oct;11(19):3853-65. doi: 10.1002/pmic.201100253. Epub 2011 Sep 7.

12.

Disinfection and sterilization of prion-contaminated medical instruments.

Belay ED, Schonberger LB, Brown P, Priola SA, Chesebro B, Will RG, Asher DM.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1304-6; author reply 1306-8. doi: 10.1086/657579. No abstract available.

PMID:
21047181
13.

Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations.

Moore RA, Timmes A, Wilmarth PA, Priola SA.

Proteomics. 2010 Aug;10(15):2858-69. doi: 10.1002/pmic.201000104.

14.

Susceptibilities of nonhuman primates to chronic wasting disease.

Race B, Meade-White KD, Miller MW, Barbian KD, Rubenstein R, LaFauci G, Cervenakova L, Favara C, Gardner D, Long D, Parnell M, Striebel J, Priola SA, Ward A, Williams ES, Race R, Chesebro B.

Emerg Infect Dis. 2009 Sep;15(9):1366-76. doi: 10.3201/eid1509.090253.

15.

The role of the prion protein membrane anchor in prion infection.

Priola SA, McNally KL.

Prion. 2009 Jul-Sep;3(3):134-8. Epub 2009 Jul 7. Review.

16.

Cells expressing anchorless prion protein are resistant to scrapie infection.

McNally KL, Ward AE, Priola SA.

J Virol. 2009 May;83(9):4469-75. doi: 10.1128/JVI.02412-08. Epub 2009 Feb 18.

17.

Prion protein misfolding and disease.

Moore RA, Taubner LM, Priola SA.

Curr Opin Struct Biol. 2009 Feb;19(1):14-22. doi: 10.1016/j.sbi.2008.12.007. Epub 2009 Jan 20. Review.

18.

Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent.

Greil CS, Vorberg IM, Ward AE, Meade-White KD, Harris DA, Priola SA.

Virology. 2008 Sep 30;379(2):284-93. doi: 10.1016/j.virol.2008.07.006. Epub 2008 Aug 8.

19.

Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1.

Caetano FA, Lopes MH, Hajj GN, Machado CF, Pinto Arantes C, Magalhães AC, Vieira Mde P, Américo TA, Massensini AR, Priola SA, Vorberg I, Gomez MV, Linden R, Prado VF, Martins VR, Prado MA.

J Neurosci. 2008 Jun 25;28(26):6691-702. doi: 10.1523/JNEUROSCI.1701-08.2008.

20.

Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking.

Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, Onwubiko HA, Priola SA, Caughey B.

Nat Methods. 2008 Mar;5(3):211-2. doi: 10.1038/nmeth0308-211. No abstract available.

PMID:
18309304
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk